Last reviewed · How we verify
Furazol (FURAZOLIDONE)
Furazol (generic name: FURAZOLIDONE) is a Monoamine Oxidase Inhibitors Small molecule drug developed by Takeda. It is currently FDA-approved (first approved 1958).
Furazol, also known as Furazolidone, is a small molecule DNA inhibitor. It has been studied in clinical trials for various gastrointestinal conditions, including peptic ulcer disease, Helicobacter pylori infection, and gastric cancer.
At a glance
| Generic name | FURAZOLIDONE |
|---|---|
| Sponsor | Takeda |
| Drug class | Monoamine Oxidase Inhibitors |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
| First approval | 1958 |
Approved indications
Common side effects
Drug interactions
- Alpha/Beta Agonists
- Amphetamines
- Indirectly Acting Sympathomimetic Amines
- Selective Serotonin Reuptake Inhibitors
- Serotonin/Norepinephrine Reuptake Inhibitors
- Tricyclic Antidepressants
- almotriptan
- buspirone
- dextromethorphan
- eletriptan
- frovatriptan
- levodopa
Key clinical trials
- Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study
- Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study (NA)
- Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE4)
- Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy (PHASE4)
- Furazolidone Quadruple Regimen Eradicate H. Pylori Infection (PHASE1,PHASE2)
- The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication (EARLY_PHASE1)
- Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE3)
- Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Furazol CI brief — competitive landscape report
- Furazol updates RSS · CI watch RSS
- Takeda portfolio CI
Frequently asked questions about Furazol
What is Furazol?
Who makes Furazol?
What is the generic name of Furazol?
What drug class is Furazol in?
When was Furazol approved?
What development phase is Furazol in?
Related
- Drug class: All Monoamine Oxidase Inhibitors drugs
- Manufacturer: Takeda — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing